Showing results (101-110 of 128) with videos related to

Sort By:
Pageof 13
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Alterations of the upper respiratory microbiome among children living with HIV infection in BotswanaSweta M Patel, John Farirai, Mohamed Z Patel, et al.
The Journal of Infectious Diseases|August 12, 2025
Alterations of the upper respiratory microbiome among children living with HIV infection in BotswanaSweta M Patel, John Farirai, Mohamed Z Patel, et al.
Plos One|January 5, 2022
Evolution of pneumococcal serotype epidemiology in Botswana following introduction of 13-valent pneumococcal conjugate vaccineSweta M Patel, Yazdani B Shaik-Dasthagirisaheb, Morgan Congdon, et al.
The Journal of Infectious Diseases|May 23, 2012
Safety and immunogenicity of 2009 pandemic H1N1 influenza vaccination in perinatally HIV-1-infected children, adolescents, and young adultsPatricia M Flynn, Sharon Nachman, Petronella Muresan, et al.
Journal of Virology|April 20, 2012
Initial HIV-1 antigen-specific CD8+ T cells in acute HIV-1 infection inhibit transmitted/founder virus replicationStephanie A Freel, Ralph A Picking, Guido Ferrari, et al.
The Journal of Infectious Diseases|March 7, 2018
Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and ChildrenUrsula J Buchholz, Coleen K Cunningham, Petronella Muresan, et al.
The Journal of Infectious Diseases|November 24, 2019
Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
The Journal of Infectious Diseases|February 2, 2020
Live-Attenuated Respiratory Syncytial Virus Vaccine With M2-2 Deletion and With Small Hydrophobic Noncoding Region Is Highly Immunogenic in ChildrenElizabeth J McFarland, Ruth A Karron, Petronella Muresan, et al.
Tropical Medicine & International Health : TM & IH|April 8, 2011
Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected children and infants in northern TanzaniaJohn A Crump, Habib O Ramadhani, Anne B Morrissey, et al.
The Lancet. HIV|April 15, 2024
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm studyCarina A Rodriguez, Eva Natukunda, Renate Strehlau, et al.
Pageof 13